$CI (Cigna Corp.)

$CI {{ '2015-10-19T20:36:48+0000' | timeago}} • Announcement

$CI extends hands with Lahey Clinical to launch its first collaborative care arrangement in Boston to improve health and lower costs. The arrangement became effect on Oct. 1 & to benefit 7,000 individuals covered under $CI health plan.

$CI {{ '2017-12-15T12:13:02+0000' | timeago}} • Announcement

$CI acquired Brighter Inc., a platform that connects patients, providers, and payers. $CI expects Brighter’s digital health plan platform will help to accelerate and expand the consumer initiatives. The financial details of the deal remained undisclosed.

$ANTM {{ '2017-12-11T14:59:25+0000' | timeago}} • Infographic

At a time when the US health insurance sector stares at a rise in premium prices, amid the government’s move to repeal the Individual Mandate clause, an analysis shows that major players in the sector registered consistent revenue growth over the past ten years. $ANTM $UNH $AET $HUM $CI

$CI {{ '2017-11-02T15:58:08+0000' | timeago}} • Announcement

For FY17, healthcare insurer $CI expects revenue to grow about 4% and adjusted EPS from operations is estimated to be $10.20-10.40. Global medical customer growth target increased to approx. 650,000 lives in FY17.

$CI {{ '2017-11-02T15:50:43+0000' | timeago}} • Announcement

Despite the volatility in healthcare insurance market, $CI posted higher profit in 3Q17, boosted by low medical costs. Shareholders' net income surged 23% to $560MM or $2.21 per share, while revenue grew 5% to $10.4Bil. Adjusted EPS from operations spiked up 46% to $2.83, which included $0.85 per share of special charges.

$CI {{ '2017-11-02T14:11:23+0000' | timeago}} • Infographic

$CI Cigna Corp. Earnings AlphaGraphic: Q3 2017 Highlights

$CI {{ '2017-10-04T19:26:28+0000' | timeago}} • Announcement

$CI is attempting to reduce opioid use among its customers by 25% by 2019. Drug lists are regularly evaluated to eliminate inappropriate use of opioids. Due to this, the brand OxyContin is no longer covered as a preferred option on $CI’s group commercial drug lists effective January 1, 2018. Doctors will be advised to seek alternative options.

$CI {{ '2017-08-04T17:58:49+0000' | timeago}} • Webcast

$CI remains committed to 10-13% long-term EPS growth rate and strategic objectives to achieve $16 of EPS out in 2021. $CI would expect to grow revenue as well as earnings off of its 2017 base. $CI has a great track record of producing very strong cash flows and it expects that to continue in 2018 as well as to maintain very strong capital position.

$CI {{ '2017-08-04T17:54:34+0000' | timeago}} • Webcast

$CI sees considerable opportunities for continued growth in its Global Supplemental Benefits business, where the company serves about 13MM customer relationships and where it has grown revenue at a compounded annual rate of 18% since 2009.

$CI {{ '2017-08-04T17:53:28+0000' | timeago}} • Webcast

$CI sees meaningful growth opportunities in its targeted international markets. The company said the global health marketplace is large, complex, and changing rapidly, which provides Cigna with potential for attractive growth and ongoing value creation.

$CI {{ '2017-08-04T12:26:09+0000' | timeago}} • Infographic

$CI Cigna Earnings AlphaGraphic: Q2 2017 Highlights

$CI {{ '2017-08-04T11:09:15+0000' | timeago}} • Announcement

$CI lifted its FY17 adjusted income from operations outlook to $2.50-2.58Bil from $2.41-2.53Bil and its adjusted EPS from operations to $9.75-10.05 from $9.25-9.75. The outlook excludes the impact of additional prior year reserve development and potential effects of any future capital deployment. Total revenue growth is still expected at 3-4%.

$CI {{ '2017-08-04T11:04:09+0000' | timeago}} • Announcement

$CI's Global Supplemental Benefits results for 2Q17 continue to reflect the value created by affordable and personalized solutions delivered directly to individual consumers through a diversified set of distribution channels. Premiums and fees for 2Q17 grew 14% over the previous year quarter, reflecting continued business growth.

$CI {{ '2017-08-04T11:02:55+0000' | timeago}} • Announcement

$CI's Global Health Care delivered strong results in 2Q17, reflecting consistent performance in well-positioned growth businesses. The medical customer base at the end of 2Q17 totaled 15.7MM, an increase of 457,000 customers year to date, driven by organic growth in all of its Commercial market segments.

$CI {{ '2017-08-04T10:59:12+0000' | timeago}} • Announcement

$CI reported a jump in 2Q17 earnings driven by strong performance across its Global Health Care, Global Supplemental Benefits and Group Disability & Life segments. Net income grew to $813MM or $3.15 per share from $510MM or $1.97 per share last year. Revenue rose 4% to $10.32Bil. Adjusted EPS from operations increased to $2.91 from $1.98.

$CI {{ '2017-06-08T17:47:25+0000' | timeago}} • Announcement

$CI and $CVS announced the launch of Cigna Health WorksSM, a new collaboration that aligns Cigna-administered health benefits with CVS Pharmacy and CVS MinuteClinic retail health care services to deliver a consumer-friendly experience for Cigna self-funded employer-sponsored health plans.

$CI {{ '2017-05-05T15:12:24+0000' | timeago}} • Webcast

$CI said that the Medicaid business in Illinois, which company has planned to exit, is running at near breakeven. $CI is not characterizing this business as a major headwind or tailwind in terms of the impact. The individual commercial business is in line with expectations and margins were negative, but still better than last year, $CI said.

$CI {{ '2017-05-05T15:02:51+0000' | timeago}} • Infographic

$CI Cigna Corp. Earnings AlphaGraphics: Q1 2017 highlights

$CI {{ '2017-05-05T14:56:28+0000' | timeago}} • Webcast

Relative to Monday's Delaware chancery court review and decision, $CI said that it will not speculate the outcome or timing on that. Earlier, $CI sued $ANTM to collect the breakup fee and damages after its merger agreement with Anthem got failed.

$CI {{ '2017-05-05T14:40:05+0000' | timeago}} • Webcast

$CI stated that Medicaid is a small business for it and saw an increase in Medicaid MCR in Texas and Illinois towards the end of the last year and elevated a little bit in 1Q17. $CI does not plan to participate in the Illinois Medicaid market beyond the end of this year. The exit of that business is considered in the outlook, the company said.

$ANTM {{ '2017-05-05T14:40:01+0000' | timeago}} • Announcement

$ANTM confirmed that it is filing a petition for a writ of certiorari with the U.S. Supreme Court, seeking review of the U.S. Court of Appeals for the D.C. Circuit’s majority decision regarding the acquisition of $CI.

Recent Transcripts

RAD (Rite Aid Corporation)
Wednesday, January 3 2018 - 10:00pm
ENZ (Enzo Biochem Inc.)
Friday, December 8 2017 - 1:30pm
VRML (Vermillion, Inc.)
Wednesday, November 8 2017 - 9:30pm
HUM (Humana Inc.)
Wednesday, November 8 2017 - 2:00pm
ATRS (Antares Pharma Inc.)
Tuesday, November 7 2017 - 1:30pm
MOH (Molina Healthcare, Inc.)
Thursday, November 2 2017 - 9:00pm
ALL (The Allstate Corporation)
Thursday, November 2 2017 - 1:00pm
CI (Cigna Corp.)
Thursday, November 2 2017 - 12:30pm
TEVA (Teva Pharmaceutical Industries Limited)
Thursday, November 2 2017 - 12:00pm
AGN (Allergan plc)
Wednesday, November 1 2017 - 12:30pm
OMI (Owens & Minor Inc.)
Wednesday, November 1 2017 - 12:00pm
AMRN (Amarin Corporation plc)
Wednesday, November 1 2017 - 12:00pm
WCG (WellCare Health Plans, Inc.)
Tuesday, October 31 2017 - 1:30pm
ABBV (AbbVie Inc.)
Friday, October 27 2017 - 1:00pm
CNO (CNO Financial Group, Inc.)
Thursday, October 26 2017 - 3:00pm
UNM (Unum Group)
Thursday, October 26 2017 - 12:00pm
LH (Laboratory Corp. of America Holdings)
Wednesday, October 25 2017 - 1:00pm
ANTM (Anthem, Inc.)
Wednesday, October 25 2017 - 12:30pm
CNC (Centene Corp.)
Tuesday, October 24 2017 - 12:30pm
NVS (Novartis AG)
Tuesday, October 24 2017 - 12:00pm

AlphaGraphics you may like